Clinical trial
Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma…
NCT00204568 · University Hospital Schleswig-Holstein, Other · Unknown status
Key facts
| NCT number | NCT00204568 |
|---|---|
| Title | Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) |
| Official title | Randomized Phase II Trial of Trofosfamide vs. Adriamycin in Elderly Patients With Previously Untreated Metastatic Soft Tissue Sarcoma |
| Lead sponsor | University Hospital Schleswig-Holstein, Other |
| Collaborators | Arbeitsgemeinschaft fur Internistische Onkologie German Sarcoma Group French Sarcoma Group |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Soft Tissue |
| Intervention type | Drug |
| Interventions | Adriamycin, Trofosfamide |
| Enrollment | 117 |
| Start date | Aug 1, 2004 |
| Primary completion | Oct 1, 2013 |
| Completion | Oct 1, 2013 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 8, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: